DK0468555T4 - Farmaceutisk præparat til rektal administrering af aktive stoffer med udbredt topisk medikeringsvirkning på kolonniveauet - Google Patents

Farmaceutisk præparat til rektal administrering af aktive stoffer med udbredt topisk medikeringsvirkning på kolonniveauet

Info

Publication number
DK0468555T4
DK0468555T4 DK91201485T DK91201485T DK0468555T4 DK 0468555 T4 DK0468555 T4 DK 0468555T4 DK 91201485 T DK91201485 T DK 91201485T DK 91201485 T DK91201485 T DK 91201485T DK 0468555 T4 DK0468555 T4 DK 0468555T4
Authority
DK
Denmark
Prior art keywords
rectal administration
pharmaceutical composition
widespread
active substances
drug effect
Prior art date
Application number
DK91201485T
Other languages
Danish (da)
English (en)
Other versions
DK0468555T3 (da
Inventor
Giuliano Frigerio
Gabriele Brunetti
Enzo Giorgetti
Emilia Chiodini
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11176813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0468555(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giuliani Spa filed Critical Giuliani Spa
Publication of DK0468555T3 publication Critical patent/DK0468555T3/da
Application granted granted Critical
Publication of DK0468555T4 publication Critical patent/DK0468555T4/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91201485T 1990-07-27 1991-06-14 Farmaceutisk præparat til rektal administrering af aktive stoffer med udbredt topisk medikeringsvirkning på kolonniveauet DK0468555T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02110490A IT1243379B (it) 1990-07-27 1990-07-27 Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico

Publications (2)

Publication Number Publication Date
DK0468555T3 DK0468555T3 (da) 1997-06-09
DK0468555T4 true DK0468555T4 (da) 2001-04-02

Family

ID=11176813

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91201485T DK0468555T4 (da) 1990-07-27 1991-06-14 Farmaceutisk præparat til rektal administrering af aktive stoffer med udbredt topisk medikeringsvirkning på kolonniveauet

Country Status (10)

Country Link
US (1) US5449520A (de)
EP (1) EP0468555B2 (de)
JP (1) JP3291301B2 (de)
AT (1) ATE146674T1 (de)
CA (1) CA2044676C (de)
DE (1) DE69123795T3 (de)
DK (1) DK0468555T4 (de)
ES (1) ES2097787T5 (de)
GR (2) GR3022790T3 (de)
IT (1) IT1243379B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
EP0808629A4 (de) * 1995-02-02 1998-03-04 Chugai Pharmaceutical Co Ltd Zubereitung von sucralfat
UA62917C2 (en) 1995-06-27 2004-01-15 Berinher Inhelheim Kg Medicinal composition for generating propellant-free aerosols
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
DE19941933A1 (de) * 1999-09-03 2001-03-15 Cognis Deutschland Gmbh Tensidsysteme
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EP1312368A1 (de) * 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
JP2005015365A (ja) * 2003-06-25 2005-01-20 Koike Kagaku Kk エアゾール型洗浄消毒剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
EP1981480A1 (de) * 2006-01-19 2008-10-22 Disphar International B.V. Schaumbildende zusammensetzung
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US7645801B2 (en) * 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
CA2781580A1 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
CN102724961A (zh) 2009-11-23 2012-10-10 希普拉有限公司 局部泡沫组合物
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
EP3115037B1 (de) 2015-07-08 2018-08-15 Dr. Falk Pharma Gmbh Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN110430869A (zh) * 2016-12-16 2019-11-08 费灵有限公司 直肠泡沫配制物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015334B1 (de) * 1977-08-04 1982-05-19 J.B. Tillott Limited Pfefferminzöl oder dessen aktive Bestandteile enthaltende Carminativa
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal

Also Published As

Publication number Publication date
DE69123795T3 (de) 2001-07-12
CA2044676C (en) 2003-04-01
DK0468555T3 (da) 1997-06-09
JPH04234315A (ja) 1992-08-24
US5449520A (en) 1995-09-12
IT9021104A1 (it) 1992-01-27
DE69123795T2 (de) 1997-07-10
CA2044676A1 (en) 1992-01-28
IT1243379B (it) 1994-06-10
EP0468555B2 (de) 2001-02-07
ES2097787T5 (es) 2001-04-01
JP3291301B2 (ja) 2002-06-10
IT9021104A0 (it) 1990-07-27
ATE146674T1 (de) 1997-01-15
DE69123795D1 (de) 1997-02-06
EP0468555A1 (de) 1992-01-29
EP0468555B1 (de) 1996-12-27
ES2097787T3 (es) 1997-04-16
GR3022790T3 (en) 1997-06-30
GR3035634T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
DK0468555T4 (da) Farmaceutisk præparat til rektal administrering af aktive stoffer med udbredt topisk medikeringsvirkning på kolonniveauet
IS2537B (is) Lyfjablanda til inngjafar um húð
DE69100849D1 (de) Verstellbare Lenksäulen-Vorrichtung.
SE0003449L (sv) Cancerhämmande kompositioner
SV1999000049A (es) Nuevas dihidropirimidinas 2 heterociclicamente sustituidas ref. lea 32793-sv
FI954228A0 (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
DK502985D0 (da) Farmaceutisk praeparat til transdermal systemisk administration af etaktivt middel
FI935728A0 (fi) Substituerade 4-fenylpyridoner och 4-fenyl-2-alkoxipyridiner
DK0450986T3 (da) Farmaceutisk nitroglycerin-præparat af typen til perkutan indgivelse
FI970331A0 (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
DK0633879T3 (da) Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE69417169D1 (de) Antineoplastische pharmazeutische Zusammensetzung enthaltend ein Fumagillolderivat und einen Platinkomplex
ITMI920979A0 (it) N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
NL7800762A (nl) Vloeibare, voor injectie geschikte farmaceu- tische samenstellingen.
ES2078101T3 (es) Derivados de flavona.
DE3854354D1 (de) Chromatographiesäule vom spritzentyp.
FI914642A0 (fi) Inklusionskomplex med silybin, deras framstaellning och dessa innehaollande farmaceutiska blandningar.
NL7413412A (nl) Afsluitschuifconstructie voor gietpannen, bestemd voor gesmolten metalen, in het bijzon- der staal.